After one month (n = 84) | |||||
---|---|---|---|---|---|
 | Age | Gender | LOS | CTT-2 | Med-aEFPT |
Age | 1 | Â | Â | Â | Â |
Gender | -.070 | 1 | Â | Â | Â |
LOS | .328** | -.089 | 1 | Â | Â |
CTT-2 | -.314** | -.014 | -.161 | 1 | Â |
Med-aEFPT | .381*** | -.071 | .061 | -.333** | 1 |
After three months (n = 77) | |||||
 | Age | Gender | LOS | CTT-2 | Med-aEFPT |
Age | 1 | Â | Â | Â | Â |
Gender | -.062 | 1 | Â | Â | Â |
LOS | .338** | -.114 | 1 | Â | Â |
CTT-2 | -.321** | .039 | -.155 | 1 | Â |
Med-aEFPT | .386** | .084 | .029 | -.332** | 1 |